Publication | Open Access
Serum HER2 as a predictive biomarker for tissue HER2 status and prognosis in patients with gastric cancer
18
Citations
17
References
2017
Year
Serum HER2 ECD could be a highly specific surrogate biomarker for tissue HER2 status in gastric cancer. Optimal cut-off criteria for predicting survival should be established.
| Year | Citations | |
|---|---|---|
Page 1
Page 1